HBOT Insurance Coverage Lookup

Indication	UHMS	Medicare / CMS	Notes	Typical cost
Carbon monoxide poisoning	Approved	Covered LCD L35021	Covered at UHMS-accredited facility. Emergency indication — immediate treatment.	Insurance; <$500 copay typical
Decompression sickness	Approved	Covered LCD L35021	Life-threatening emergency; recompression per USN TT6.	Insurance; no copay for emergency
Gas gangrene (clostridial myonecrosis)	Approved	Covered LCD L35021	Adjunct to surgical debridement + antibiotics.	Insurance
Crush injury / compartment syndrome	Approved	Covered LCD L35021	Gustilo IIIb/IIIc; must document trauma severity.	Insurance
Diabetic foot ulcer (Wagner 3+)	Approved	Covered LCD L35021	Requires documentation: Wagner ≥3, failed 30 days standard wound care, TcPO2 testing. 2.4 ATA standard.	Insurance covered; ~$450/session
Delayed radiation injury	Approved	Covered LCD L35021	Soft tissue + bony necrosis. Marx protocol (20+10) for ORN prophylaxis.	Insurance
Compromised skin grafts & flaps	Approved	Covered LCD L35021	Threatened graft/flap only, not routine prophylaxis.	Insurance
Chronic refractory osteomyelitis	Approved	Covered LCD L35021	Must have failed standard antibiotic + surgical therapy.	Insurance
Necrotising soft tissue infection	Approved	Covered LCD L35021	Adjunct to urgent surgical debridement.	Insurance
Intracranial abscess	Approved	Covered LCD L35021	Adjunct to surgical drainage + antibiotics.	Insurance
Severe anaemia (exceptional blood loss)	Approved	Covered LCD L35021	When transfusion impossible (Jehovahs Witness, incompatibility, etc.).	Insurance
Thermal burns	Approved	Covered LCD L35021	Selected cases; evidence base is largely burn-centre observational.	Insurance
Air or gas embolism	Approved	Covered LCD L35021	Iatrogenic or diving-related; immediate recompression.	Insurance; emergency
Sudden sensorineural hearing loss	Approved	Covered (since 2021) LCD L35021	Time-sensitive — must be initiated within 14 days of onset. UHMS added 2019; CMS covered 2021.	Insurance
Traumatic brain injury (TBI)	Off-label	Not covered	Off-label. Growing RCT evidence (Efrati Lab). Some VA pilot programmes, state TBI programmes (OK, TX, FL) provide access.	Cash-pay $6,000–$18,000 for 40 sessions
Post-concussion syndrome	Off-label	Not covered	Same evidence base as TBI; off-label.	Cash-pay
Stroke (chronic recovery)	Off-label	Not covered	Off-label for chronic phase. Acute stroke is not standard HBOT indication.	Cash-pay
Long COVID / PASC	Off-label	Not covered	Off-label. Zilberman-Itskovich 2022 RCT at 2.0 ATA. Not covered by CMS or major private insurers.	Cash-pay $6,000–$18,000
Fibromyalgia	Off-label	Not covered	Off-label; Efrati 2015 trial supports symptom benefit at 2.0 ATA.	Cash-pay
PTSD	Off-label	Not covered	Off-label; mixed trial evidence (Harch 2017 vs Cifu 2014). Some veteran-specific state programmes.	Cash-pay / state programmes for veterans
Autism spectrum disorder	Off-label	Not covered	Off-label; evidence contested. Rossignol 2009 vs follow-up trials.	Cash-pay
Cerebral palsy	Off-label	Not covered	Off-label; Collet 2001 Lancet trial sham/active both improved.	Cash-pay
Anti-aging / longevity	Off-label	Not covered	Off-label wellness use. Hachmo 2020 telomere study used 2.0 ATA.	Cash-pay $6,000–$18,000
Sports recovery / DOMS	Off-label	Not covered	Off-label; limited RCT support (Babul 2003 negative).	Cash-pay
Multiple sclerosis	Off-label	Not covered	Not supported by Bennett 2011 Cochrane. Widely used off-label at UK MS Therapy Centres regardless.	Cash-pay / UK MS Centres
Avascular necrosis (femoral head)	Approved	Variable (LCD-dependent)	UHMS-approved (14th edition). Coverage varies by Medicare contractor; some private payers deny.	Insurance (variable); cash-pay fallback

Important: This reference reflects general US payer policy at the time of writing. Coverage criteria change — always verify current status with your specific insurer, the UHMS-accredited facility, and the Medicare contractor for your region.